No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
VSTM Verastem
- 9.8400
- -0.3900-3.81%
Close Apr 19 16:00 ET
- 10.0500
- +0.2100+2.13%
Post 18:31 ET
249.03MMarket Cap-2484P/E (TTM)
10.3550High9.5600Low151.40KVolume10.1000Open10.2300Pre Close1.48MTurnover1.11%Turnover RatioLossP/E (Static)25.31MShares15.180052wk High4.34P/B134.70MFloat Cap4.260052wk Low--Dividend TTM13.69MShs Float225.8400Historical High--Div YieldTTM7.77%Amplitude3.4740Historical Low9.7760Avg Price1Lot Size
Post-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | Verastem Oncology Announces Appointment of John Hayslip, M.d., to Chief Medical Officer
Analysts Offer Insights on Healthcare Companies: Verastem (VSTM), Laboratory (LH) and Longboard Pharmaceuticals (LBPH)
VS-6766 Drug Research 2024: Developed by Verastem Oncology, An RAF/MEK Clamp That Induces Inactive Complexes of MEK With ARAF, BRAF, and CRAF - Market Size, Forecast, and Emerging Insights 2019-2032
Analysts Offer Insights on Healthcare Companies: Shattuck Labs (STTK) and Verastem (VSTM)
Verastem Releases Updated Corporate Presentation for Investors
Express News | Verastem Oncology Partner GenFleet Therapeutics Unveils Latest Research Findings Of GFH375 At AACR Annual Meeting
Comments
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
baglady : way to go!